stockportfolio.pro
Stocks / IONS vs RVTY
IONS vs RVTY
Ionis Pharmaceuticals, Inc. and Revvity, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Ionis Pharmaceuticals, Inc. (IONS) | Revvity, Inc. (RVTY) | |
|---|---|---|
| Market cap | $12.2B | $11.6B |
| Revenue (latest FY) | $943.71M | $2.86B |
| Net income (latest FY) | $-381.39M | $241.20M |
| Revenue growth (5y CAGR) | 5.3% | -5.5% |
| Net margin | -40.4% | 8.4% |
| Return on equity | -78.0% | 3.3% |
| P/E ratio | — | 50.1 |
| Dividend yield | — | 0.3% |
| Profitable years (of last 10) | 3 | 10 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open IONS — free Open RVTY — freeFrequently asked questions
Which is bigger, IONS or RVTY?
Ionis Pharmaceuticals, Inc. is larger by market capitalization — $12.2B versus $11.6B.
Which grows faster, IONS or RVTY?
Over the last five fiscal years, Ionis Pharmaceuticals, Inc. grew revenue faster — 5.3%/yr versus -5.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.